| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 154,405 | 157,817 | 164,195 | 161,344 | | Cost of Revenue | 48,089 | 37,049 | 51,136 | 43,124 | | | Gross Profit | 106,316 | 120,768 | 113,059 | 118,220 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 690 | 17,338 | 8,784 | 50,265 | | Non Recurring | 13,551 | 41,951 | 84,428 |
-
| | Others | (192,816) | 197,407 | 80,234 | 169,307 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 284,891 | (135,928) | (60,387) | (101,352) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (425,692) |
-
| 107,229 | 181,934 | | Earnings Before Interest And Taxes | (142,004) | (138,140) | (58,175) | 38,391 | | Interest Expense | 56,000 | 58,159 | 65,352 | 70,026 | | Income Before Tax | (198,004) | (196,299) | (123,527) | (31,635) | | Income Tax Expense | 88 | 134 | 2,267 | 36 | | Minority Interest |
-
| 20 | (20) | (165) | | | | Net Income From Continuing Ops | (202,279) | (192,226) | (18,585) | 12,020 | | | Non-recurring Events | | Discontinued Operations | 1,560 | (4,585) | (6,370) | (243) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (199,775) | (196,811) | (24,955) | 11,777 | | Preferred Stock And Other Adjustments | (3,341) | (1,331) | (2,336) | (2,336) | | | Net Income Applicable To Common Shares | ($203,116) | ($198,142) | ($27,291) | $9,441 |
|
0.51% Nasdaq 
Income Statement
